Trial Profile
A Phase I Study Investigating the Combination of RAD001 With Standard Induction and Consolidation Therapy in Older Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Oct 2022
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Cytarabine; Etoposide; Idarubicin; Mitoxantrone
- Indications Acute myeloid leukaemia
- Focus Adverse reactions
- Acronyms AML1208
- 24 Oct 2022 Status changed from active, no longer recruiting to completed.
- 22 Oct 2018 Planned End Date changed from 1 Mar 2018 to 1 Dec 2018.
- 20 Feb 2018 Planned End Date changed from 1 Dec 2017 to 1 Mar 2018.